Price target upside
Acrivon Therapeutics Price Target: +422.7% vs Current Price
ACRV target gap is +422.7% from $2.20 to $11.50. As of 2026-08-21.
Direct answer
Acrivon Therapeutics's analyst target implies +422.7%.
The average target is $11.50 compared with a recorded current price of $2.20.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 21, 2026.
Get free Acrivon Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.20
- Average price target
- $11.50
- High price target
- $19.00
- Low price target
- $7.00
- Low target gap
- +218.2%
- Target upside
- +422.7%
- High target gap
- +763.6%
- Target range width
- 545.5%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Acrivon Therapeutics's average target imply?
Acrivon Therapeutics's average target is $11.50 versus a recorded price of $2.20. The difference is +422.7%.
How far are Acrivon Therapeutics's low and high targets from the recorded price?
The low target implies +218.2%, while the high target implies +763.6%.
How many analysts are included in Acrivon Therapeutics's consensus?
The verified consensus includes 6 analysts.
How is Acrivon Therapeutics's target upside or downside calculated?
The average target of $11.50 is divided by the recorded price of $2.20, then one is subtracted to produce +422.7%. This does not guarantee a future return.
When was Acrivon Therapeutics's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.